Since 2018, the illicit drug supply in British Columbia, Canada, has become increasingly toxic, with fentanyl often mixed with nonpharmaceutical benzodiazepines. This presentation examines the impact of "benzodope" on incarcerated individuals, focusing on benzodiazepine withdrawal challenges and how it is reshaping withdrawal management and substance use treatment in prison settings.

• Examine how the changing illicit drug supply has affected incarcerated people
• Describe how changes to illicit substance use are affecting withdrawal and substance use treatment in prisons
• Discuss quality improvement initiatives aimed at improving health outcomes for incarcerated people

Level: Basic